Göm menyn

Publications for Andrea Lindgren (Koch)

Co-author map based on Web of Sciences articles 2007-

Publications mentioned in social media 8 times*

Journal Articles

Miklos Gulyas, Johanna Sofia Margareta Mattsson, Andrea Lindgren, Lars Ek, Kristina Lamberg Lundström, Annelie Behndig, Erik Holmberg, Patrick Micke, Bengt Bergman and The Swedish Lung Cancer Study Group
  COX-2 expression and effects of celecoxib in addition to standard chemotherapy in advanced non-small cell lung cancer
  Acta Oncologica, 2018, 57(2), 244-250.
 Web of Science® Times Cited: 1

Henrik Green, Johanna Hasmats, Ilya Kupershmidt, Daniel Edsgard, Luigi de Petris, Rolf Lewensohn, Fiona Blackhall, Svante Vikingsson, Benjamin Besse, Andrea Lindgren, Eva Branden, Hirsh Koyi, Curt Peterson and Joakim Lundeberg
  Using Whole-Exome Sequencing to Identify Genetic Markers for Carboplatin and Gemcitabine-Induced Toxicities
  Clinical Cancer Research, 2016, 22(2), 366-373.
 Web of Science® Times Cited: 5

Sverre Sörenson, Helena Fohlin, Andrea Lindgren, Magnus Lindskog, Bengt Bergman, Christer Sederholm, Lars Ek, Kristina Lamberg and Birgitta Clinchy
  Predictive role of plasma vascular endothelial growth factor for the effect of celecoxib in advanced non-small cell lung cancer treated with chemotherapy
  European Journal of Cancer, 2013, 49(1), 115-120.
   Fulltext  PDF  
 Web of Science® Times Cited: 8

Andrea Koch, Bertil Gustafsson, Helena Fohlin and Sverre Sörenson
  Cyclooxygenase-2 expression in lung cancer cells evaluated by immunocytochemistry
  Diagnostic Cytopathology, 2011, 39(3), 188-193.
 Web of Science® Times Cited: 7

Andrea Koch, Bengt Bergman, Erik Holmberg, Christer Sederholm, Lars Ek, Jaroslaw Kosieradzki, Kristina Lamberg, Lars Thaning, Sven-Olof Ydreborg and Sverre Sörenson
  Effect of celecoxib on survival in patients with advanced non-small cell lung cancer: A double blind randomised clinical phase III trial (CYCLUS study) by the Swedish Lung Cancer Study Group
  European Journal of Cancer, 2011, 47(10), 1546-1555.
 Web of Science® Times Cited: 24

Andrea Koch, Helena Fohlin and Sverre Sörenson
  Prognostic significance of C-reactive protein and smoking in patients with advanced non-small cell lung cancer treated with first-line palliative chemotherapy.
  Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2009, 4(3), 326-32.
 Web of Science® Times Cited: 61

Andrea Koch, Sverre Sörenson, Asgeir Askeland and Tor Aasen
  Rapportering av yrkesrelatert lungekreft.
  Lungeforum, 2003, 13, 12-16.

Conference Articles

Andrea Koch, Sverre Sörenson, H Fohlin and B Gustafsson
  Expression of cyclooxygenase-2 in cytological material from patients with lung cancer in EJC SUPPLEMENTS, vol 7, issue 2, pp 513-513

Ph.D. Theses

Andrea Koch
  Clinical Aspects of Inflammation in Non-small Cell Lung Cancer

  Fulltext PDF

* Social media data based on publications from 2011 to present and with a DOI; data delivered by Altmetric.com.


Responsible for this page: Peter Berkesand
Last updated: 2010-08-30